Dehaier Medical Cooperates With Mindray to Win Procurement Bid
February 12 2013 - 7:30AM
Dehaier Medical Systems Ltd. (Nasdaq:DHRM)
("Dehaier" or the "Company"), an emerging leader in the
development, assembly, marketing and sale of medical devices and
homecare medical products, today announced that it assisted Mindray
Medical International Ltd (NYSE:MR) with a national medical
procurement bid for 79 units of Mindray's M7 color Doppler
ultrasound machines.
Mr. Ping Chen, Chairman and Chief Executive Officer of Dehaier
Medical said, "The opportunity to cooperate with a well-respected
company like Mindray and the national level of the procurement
project made this an important bid for our company. I am proud of
our team's successful bid and believe it reflects well on our
experience participating in governmental procurement projects,
excellent public relations efforts and strong implementation
capability. We expect the project to contribute significantly to
revenue this year and set a firm foundation for our key account
business in 2013. We will use this project and cooperation with
Mindray to continue to develop our corporate growth strategy and to
enhance Dehaier's brand awareness."
About Dehaier Medical Systems
Ltd.
Dehaier is an emerging leader in the development, assembly,
marketing and sale of medical products, including respiratory and
oxygen homecare medical products. The company develops and
assembles its own branded medical devices and homecare medical
products from third-party components. The company also distributes
products designed and manufactured by other companies, including
medical devices from IMD (Italy), Welch Allyn (USA), HEYER
(Germany), Timesco (UK), eVent Medical (US) and JMS (Japan).
Dehaier's technology is based on six patents, ten software
copyrights and proprietary technology. More information may be
found at http://www.dehaier.com.cn
About Mindray Medical International Ltd
Mindray is a leading developer, manufacturer and marketer of
medical devices worldwide. Mindray maintains its global
headquarters in Shenzhen, China, U.S. headquarters in Mahwah,
New Jersey and multiple sales offices in major international
markets. From the main manufacturing and engineering base
in China, Mindray supply through its worldwide distribution
network a broad range of products across three primary business
segments, namely patient monitoring and life support, in-vitro
diagnostic, and medical imaging systems.
Forward-looking Statements
This news release contains forward-looking statements as defined
by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events, government approvals
or performance, and underlying assumptions and other statements
that are other than statements of historical facts, including in
particular any implications regarding the implementation of the
ultrasound machine procurement agreement. These statements are
subject to uncertainties and risks including, but not limited to,
product and service demand and acceptance, changes in technology,
economic conditions, the impact of competition and pricing,
government regulation, future developments in payment for and
demand for medical equipment and services, implementation of and
performance under the joint venture agreement by all parties, and
other risks contained in reports filed by the company with the
Securities and Exchange Commission. All such forward-looking
statements, whether written or oral, and whether made by or on
behalf of the company, are expressly qualified by the cautionary
statements and any other cautionary statements which may accompany
the forward-looking statements. In addition, the company disclaims
any obligation to update any forward-looking statements to reflect
events or circumstances after the date hereof.
CONTACT: Dehaier Medical Systems Limited
Surie Liu
+86 10-5166-0080
lius@dehaier.com.cn
Dehaier Medical Systems Limited
Tina He
+86 10-5166-0080
hexw@dehaier.com.cn
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lianluo Smart (NASDAQ:LLIT)
Historical Stock Chart
From Jul 2023 to Jul 2024